Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing <it>Escherichia coli </it>and <it>Klebsiella pneumoniae</it>
<p>Abstract</p> <p>Background</p> <p>Prompt administration of adequate empiric antimicrobial therapy is a major determinant influencing the outcome of serious infections. The objective of this study was to describe empiric antimicrobial therapy employed and assess its e...
Main Authors: | Dalton Bruce, Pitout Johann DD, Chaubey Vikas P, Ross Terry, Church Deirdre L, Gregson Daniel B, Laupland Kevin B |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-04-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/3/116 |
Similar Items
-
Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
by: Johann D.D. Pitout, et al.
Published: (2007-03-01) -
Population-based laboratory surveillance of <it>Hafnia alvei </it>isolates in a large Canadian health region
by: Laupland Kevin B, et al.
Published: (2006-05-01) -
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy
by: Chih-Chao Yang, et al.
Published: (2014-11-01) -
Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
by: Yuko Komatsu, et al.
Published: (2018-01-01) -
Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative
by: Church Deirdre L, et al.
Published: (2009-07-01)